Molecular Imaging

Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI. Molecular imaging includes the field of nuclear medicine, which uses very small amounts of radioactive materials, or radiopharmaceuticals, to diagnose and treat disease.

IBA, a world leader in particle accelerator technology and the leading provider of radiopharmaceuticals production solutions, announced that it has launched a new low energy and compact size cyclotron, the Cyclone KEY.
News | Nuclear Imaging
IBA Launches Compact Low-Energy Cyclotron, Cyclone KEY

January 26, 2022 — IBA, a world leader in particle accelerator technology and the leading provider of ...

Time January 26, 2022
arrow
PET disease extent in EAU BCR low-risk patients, EAU BCR high-risk patients, and BCP patients (A) and predictors of PET M1 disease (B). OR = odds ratio. Image courtesy of Justin Ferdinandus, Wolfgang P. Fendler, Andrea Farolfi, et al.
News | Prostate Cancer
PSMA PET Validates EAU Classification System to Determine Risk of Prostate Cancer Recurrence

January 24, 2022 — New research has confirmed the accuracy of the novel European Association of Urology (EAU) risk ...

Time January 24, 2022
arrow
The Task Force members have recently observed an unusual imaging pattern on FDG PET/CT or FDG PET/MR that may be due to COVID-19 infection. 
News | Coronavirus (COVID-19)
SNMMI Task Force Reports Possible Effect of Omicron Infection on FDG PET/CT Scans

January 17, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) issued a statement on Jan. 14 regarding ...

Time January 17, 2022
arrow
Case examples of quantitative plaque analysis on coronary CT angiography and 18F-NaF PET in patients with established coronary artery disease. Hybrid CT angiography and 18F-NaF PET of coronary arteries. (A) A 70-y-old male, who presented with diffused largely noncalcified disease (middle panel in red) in the LAD and demonstrated increased 18F-NaF uptake in the LAD on PET. (B) A 59-y-old male with mild LCX atherosclerosis, who presented with a high noncalcified plaque burden (middle panel in red) on CT angio
News | PET-CT
PET/CT Artificial Intelligence Model Ideal for Predicting Risk of Future Heart Attack

January 12, 2022 — By combining information from two advanced imaging techniques with clinical data, physicians can ...

Time January 12, 2022
arrow
From left-to-right are examples of a true object, a reconstructed estimate of the object produced by use of a U-Net from tomographic measurements, the total error map, the error in the null component of the reconstructed object, and the error in the measurement component of the reconstructed object. The two rows correspond to different objects. In each case, the true object is outside the respective training data distribution of the U-Net and phase noise was added to the measurements prior to image reconstr
News | Radiology Imaging
Investigating Hallucinations in Medical Imaging

January 12, 2022 — Machine-learning methods are being actively developed for computed imaging systems like magnetic ...

Time January 12, 2022
arrow
PET CT image of the Neck showing CA nasopharynx or carcinoma of nasopharynx from PET CT scannner.
News | PET Imaging
Clario and XingImaging Expand Partnership to Deliver PET Imaging Clinical Trials in China 

January 11, 2022 — Clario, a technology company that delivers the leading endpoint technology solutions for clinical ...

Time January 11, 2022
arrow
NNSA’s lease contract will provide SHINE with the low-enriched uranium necessary to produce Mo-99 while DOE-EM’s contract details requirements surrounding the return of any resulting radioactive waste unable to be disposed of commercially once Mo-99 production is complete.
News | Molecular Imaging
DOE Offices and SHINE Sign First-ever Contracts Under Uranium Lease and Take-back Program to Produce Domestic Mo-99

Janaury 10, 2022 — The Department of Energy’s National Nuclear Security Administration (NNSA) and Office of ...

Time January 10, 2022
arrow
Aquilion Exceed LB CT System offers industry’s largest bore and widest field-of-view
News | Computed Tomography (CT)
Computed Tomography (CT) Scanners Devices and Equipment Global Market Report 2021

January 3, 2022 — The "Computed Tomography (CT) Scanners Devices and Equipment Global Market Report 2021: COVID-19 ...

Time January 03, 2022
arrow
IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, announced a new contract for the installation of a Proteus ONE[1] proton therapy solution with Proton International Arkansas LLC – a joint venture formed by Proton International, the University of Arkansas for Medical Sciences (UAMS), Baptist Health, and Arkansas Children’s.
News | Proton Therapy
IBA and Proton International Sign Contract for Proteus ONE Proton Therapy Solution in Arkansas

January 3, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and ...

Time January 03, 2022
arrow
Image from a co-registered PET-CT study from dual modality scanner. Patient with multiple metastatic lesions in liver & lung. PET data superimposed over CT scan axial slice through lung metastases
News | Molecular Imaging
Global Nuclear Imaging Market Report

December 29, 2021 — The global nuclear imaging devices and equipment market is expected to grow from $2.45 billion in ...

Time December 29, 2021
arrow
Figure courtesy of Nature Biomedical Engineering
News | Magnetic Resonance Imaging (MRI)
Magnetic Resonance Imaging and Artificial Intelligence Can Detect Early Signs of Tumor Cell Death After Novel Therapy

December 27, 2021 — In a recent study published in Nature Biomedical Engineering, a team led by researchers at ...

Time December 27, 2021
arrow
Mirion Technologies, Inc., a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the signing of a definitive agreement to acquire Computerized Imaging Reference Systems, Inc. (“CIRS”), a leading provider of medical imaging and radiation therapy phantoms serving the medical industry.
News | Radiation Therapy
Mirion Technologies to Acquire Computerized Imaging Reference Systems

December 10, 2021 — Mirion Technologies, Inc., a global provider of detection, measurement, analysis and monitoring ...

Time December 10, 2021
arrow
Carl Bjartmar
News | Molecular Imaging
Ascelia Pharma Presents Study Showing Comparable Efficacy of Orviglance Lesion Visualization and Detection to Gadolinium

December 7, 2021 — Orviglance* is a novel manganese-based oral contrast agent for magnetic resonance imaging (MRI) ...

Time December 07, 2021
arrow
After the absorption of an X-ray photon, the water molecule can bend up so far that after only about ten femtoseconds (quadrillionths of a second) both hydrogen atoms (grey) are facing each other, with the oxygen atom (red) in the middle. This motion can be studied by absorbing a second X-ray photon. Credit: DESY, Ludger Inhester
News | Molecular Imaging
X-ray Laser Reveals How Radiation Damage Arises

December 7, 2021 — An international research team has used the X-ray laser European XFEL to gain new insights into how ...

Time December 07, 2021
arrow
CIRS specializes in the design, development and commercialization of tissue equivalent medical imaging and radiation therapy phantoms for the radiotherapy and radio-diagnostic markets.
News | Nuclear Imaging
Mirion Technologies Completes Acquisition of Computerized Imaging Reference Systems, Inc.

December 3, 2021 — Mirion Technologies, Inc., a global provider of detection, measurement, analysis and monitoring ...

Time December 03, 2021
arrow
News | Computed Tomography (CT)
Philips Collaborates With Leading Institutes to Bring Its Breakthrough Spectral CT Imaging into the Interventional Suite

November 28, 2021 — Royal Philips, a leader in health technology, unveiled its vision for interventional medicine by ...

Time November 28, 2021
arrow
IBA, a leader in particle accelerator technology, and NorthStar Medical Radioisotopes LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced a new contract in which NorthStar will purchase a third Rhodotron TT300 HE electron beam accelerator from IBA.
News | Nuclear Imaging
IBA and NorthStar Medical Radioisotopes Sign Contract for Rhodotron Electron Beam Accelerator for Commercial Production of Therapeutic Radioisotope Actinium-225 (Ac-225)

November 22, 2021 — IBA, a leader in particle accelerator technology, and NorthStar Medical Radioisotopes LLC, a global ...

Time November 22, 2021
arrow
Videos | Radiopharmaceuticals and Tracers
VIDEO: Advances in Radiopharmaceutical Therapy

Ana Kiess, M.D., Ph.D., assistant professor of radiation oncology and molecular radiation sciences, Johns Hopkins ...

Time November 17, 2021
arrow
Videos | Radiation Oncology
VIDEO: MRI-Linac and PSMA PET Imaging Technologies Aids Therapy at GenesisCare

Walter Curran, Jr. M.D., FACR, FASCO, GenesisCare global chief medical officer, discusses three technologies that are ...

Time November 16, 2021
arrow
Saltus Biotech, a leader in 8k image technology, introduces a new high-end computer workstation and 8k monitor system for digital pathology for live tissue biopsy movies in real time. Saltus 8k imaging system monitors microscopic movies of live biological tissue specimens in real time.
News | Digital Pathology
Real-time Monitoring for Digital Pathology of Live Biological Tissue Specimens

November 15, 2021 — Saltus Biotech, a leader in 8k image technology, introduces a new high-end computer workstation and ...

Time November 15, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now